Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Renal and Cardiovascular Risk According to Tertiles of Urinary Albumin-to-Creatinine Ratio: The Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT).

Marcovecchio ML, Chiesa ST, Armitage J, Daneman D, Donaghue KC, Jones TW, Mahmud FH, Marshall SM, Neil HAW, Dalton RN, Deanfield J, Dunger DB; Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT) Study Group.

Diabetes Care. 2018 Sep;41(9):1963-1969. doi: 10.2337/dc18-1125. Epub 2018 Jul 19.

PMID:
30026334
2.

ACE Inhibitors and Statins in Adolescents with Type 1 Diabetes.

Marcovecchio ML, Chiesa ST, Bond S, Daneman D, Dawson S, Donaghue KC, Jones TW, Mahmud FH, Marshall SM, Neil HAW, Dalton RN, Deanfield J, Dunger DB; AdDIT Study Group.

N Engl J Med. 2017 Nov 2;377(18):1733-1745. doi: 10.1056/NEJMoa1703518.

3.

Program Evaluation of the Inner South Community Health Oral Health Program for Priority Populations.

Oldroyd JC, White S, Stephens M, Neil AA, Nanayakkara V.

J Health Care Poor Underserved. 2017;28(3):1222-1239. doi: 10.1353/hpu.2017.0107.

PMID:
28804088
4.

Meta-analysis of genome-wide association studies of HDL cholesterol response to statins.

Postmus I, Warren HR, Trompet S, Arsenault BJ, Avery CL, Bis JC, Chasman DI, de Keyser CE, Deshmukh HA, Evans DS, Feng Q, Li X, Smit RA, Smith AV, Sun F, Taylor KD, Arnold AM, Barnes MR, Barratt BJ, Betteridge J, Boekholdt SM, Boerwinkle E, Buckley BM, Chen YI, de Craen AJ, Cummings SR, Denny JC, Dubé MP, Durrington PN, Eiriksdottir G, Ford I, Guo X, Harris TB, Heckbert SR, Hofman A, Hovingh GK, Kastelein JJ, Launer LJ, Liu CT, Liu Y, Lumley T, McKeigue PM, Munroe PB, Neil A, Nickerson DA, Nyberg F, O'Brien E, O'Donnell CJ, Post W, Poulter N, Vasan RS, Rice K, Rich SS, Rivadeneira F, Sattar N, Sever P, Shaw-Hawkins S, Shields DC, Slagboom PE, Smith NL, Smith JD, Sotoodehnia N, Stanton A, Stott DJ, Stricker BH, Stürmer T, Uitterlinden AG, Wei WQ, Westendorp RG, Whitsel EA, Wiggins KL, Wilke RA, Ballantyne CM, Colhoun HM, Cupples LA, Franco OH, Gudnason V, Hitman G, Palmer CN, Psaty BM, Ridker PM, Stafford JM, Stein CM, Tardif JC, Caulfield MJ, Jukema JW, Rotter JI, Krauss RM.

J Med Genet. 2016 Dec;53(12):835-845. doi: 10.1136/jmedgenet-2016-103966. Epub 2016 Sep 1.

5.

Differing predictive relationships between baseline LDL-C, systolic blood pressure, and cardiovascular outcomes.

Deedwania PC, Pedersen TR, DeMicco DA, Breazna A, Betteridge DJ, Hitman GA, Durrington P, Neil A; TNT, CARDS and IDEAL Steering Committees and Investigators.

Int J Cardiol. 2016 Nov 1;222:548-556. doi: 10.1016/j.ijcard.2016.07.201. Epub 2016 Jul 30.

PMID:
27513651
6.

Livelihoods and Fisheries Governance in a Contemporary Pacific Island Setting.

Sulu RJ, Eriksson H, Schwarz AM, Andrew NL, Orirana G, Sukulu M, Oeta J, Harohau D, Sibiti S, Toritela A, Beare D.

PLoS One. 2015 Nov 23;10(11):e0143516. doi: 10.1371/journal.pone.0143516. eCollection 2015.

7.

Effect of atorvastatin on glycaemia progression in patients with diabetes: an analysis from the Collaborative Atorvastatin in Diabetes Trial (CARDS).

Livingstone SJ, Looker HC, Akbar T, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Fuller JH, Colhoun HM.

Diabetologia. 2016 Feb;59(2):299-306. doi: 10.1007/s00125-015-3802-6. Epub 2015 Nov 17.

8.

Effect of atorvastatin on C-reactive protein and benefits for cardiovascular disease in patients with type 2 diabetes: analyses from the Collaborative Atorvastatin Diabetes Trial.

Soedamah-Muthu SS, Livingstone SJ, Charlton-Menys V, Betteridge DJ, Hitman GA, Neil HA, Bao W, DeMicco DA, Preston GM, Fuller JH, Stehouwer CD, Schalkwijk CG, Durrington PN, Colhoun HM; CARDS Investigators.

Diabetologia. 2015 Jul;58(7):1494-502. doi: 10.1007/s00125-015-3586-8. Epub 2015 Apr 22.

9.

The contribution of nearshore fish aggregating devices (FADs) to food security and livelihoods in Solomon Islands.

Albert JA, Beare D, Schwarz AM, Albert S, Warren R, Teri J, Siota F, Andrew NL.

PLoS One. 2014 Dec 16;9(12):e115386. doi: 10.1371/journal.pone.0115386. eCollection 2014.

10.

Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins.

Postmus I, Trompet S, Deshmukh HA, Barnes MR, Li X, Warren HR, Chasman DI, Zhou K, Arsenault BJ, Donnelly LA, Wiggins KL, Avery CL, Griffin P, Feng Q, Taylor KD, Li G, Evans DS, Smith AV, de Keyser CE, Johnson AD, de Craen AJ, Stott DJ, Buckley BM, Ford I, Westendorp RG, Slagboom PE, Sattar N, Munroe PB, Sever P, Poulter N, Stanton A, Shields DC, O'Brien E, Shaw-Hawkins S, Chen YD, Nickerson DA, Smith JD, Dubé MP, Boekholdt SM, Hovingh GK, Kastelein JJ, McKeigue PM, Betteridge J, Neil A, Durrington PN, Doney A, Carr F, Morris A, McCarthy MI, Groop L, Ahlqvist E; Welcome Trust Case Control Consortium, Bis JC, Rice K, Smith NL, Lumley T, Whitsel EA, Stürmer T, Boerwinkle E, Ngwa JS, O'Donnell CJ, Vasan RS, Wei WQ, Wilke RA, Liu CT, Sun F, Guo X, Heckbert SR, Post W, Sotoodehnia N, Arnold AM, Stafford JM, Ding J, Herrington DM, Kritchevsky SB, Eiriksdottir G, Launer LJ, Harris TB, Chu AY, Giulianini F, MacFadyen JG, Barratt BJ, Nyberg F, Stricker BH, Uitterlinden AG, Hofman A, Rivadeneira F, Emilsson V, Franco OH, Ridker PM, Gudnason V, Liu Y, Denny JC, Ballantyne CM, Rotter JI, Adrienne Cupples L, Psaty BM, Palmer CN, Tardif JC, Colhoun HM, Hitman G, Krauss RM, Wouter Jukema J, Caulfield MJ.

Nat Commun. 2014 Oct 28;5:5068. doi: 10.1038/ncomms6068.

11.

Whole exome sequencing of familial hypercholesterolaemia patients negative for LDLR/APOB/PCSK9 mutations.

Futema M, Plagnol V, Li K, Whittall RA, Neil HA, Seed M; Simon Broome Consortium, Bertolini S, Calandra S, Descamps OS, Graham CA, Hegele RA, Karpe F, Durst R, Leitersdorf E, Lench N, Nair DR, Soran H, Van Bockxmeer FM; UK10K Consortium, Humphries SE.

J Med Genet. 2014 Aug;51(8):537-44. doi: 10.1136/jmedgenet-2014-102405. Epub 2014 Jul 1.

12.

The Coral Triangle Atlas: an integrated online spatial database system for improving coral reef management.

Cros A, Ahamad Fatan N, White A, Teoh SJ, Tan S, Handayani C, Huang C, Peterson N, Venegas Li R, Siry HY, Fitriana R, Gove J, Acoba T, Knight M, Acosta R, Andrew N, Beare D.

PLoS One. 2014 Jun 18;9(6):e96332. doi: 10.1371/journal.pone.0096332. eCollection 2014.

13.

Identifying genetic risk variants for coronary heart disease in familial hypercholesterolemia: an extreme genetics approach.

Versmissen J, Oosterveer DM, Yazdanpanah M, Dehghan A, Hólm H, Erdman J, Aulchenko YS, Thorleifsson G, Schunkert H, Huijgen R, Vongpromek R, Uitterlinden AG, Defesche JC, van Duijn CM, Mulder M, Dadd T, Karlsson HD, Ordovas J, Kindt I, Jarman A, Hofman A, van Vark-van der Zee L, Blommesteijn-Touw AC, Kwekkeboom J, Liem AH, van der Ouderaa FJ, Calandra S, Bertolini S, Averna M, Langslet G, Ose L, Ros E, Almagro F, de Leeuw PW, Civeira F, Masana L, Pintó X, Simoons ML, Schinkel AF, Green MR, Zwinderman AH, Johnson KJ, Schaefer A, Neil A, Witteman JC, Humphries SE, Kastelein JJ, Sijbrands EJ.

Eur J Hum Genet. 2015 Mar;23(3):381-7. doi: 10.1038/ejhg.2014.101. Epub 2014 Jun 11.

14.

LADA and CARDS: a prospective study of clinical outcome in established adult-onset autoimmune diabetes.

Hawa MI, Buchan AP, Ola T, Wun CC, DeMicco DA, Bao W, Betteridge DJ, Durrington PN, Fuller JH, Neil HA, Colhoun H, Leslie RD, Hitman GA.

Diabetes Care. 2014 Jun;37(6):1643-9. doi: 10.2337/dc13-2383. Epub 2014 Apr 10.

PMID:
24722498
15.

Optimal strategies for identifying kidney disease in diabetes: properties of screening tests, progression of renal dysfunction and impact of treatment - systematic review and modelling of progression and cost-effectiveness.

Farmer AJ, Stevens R, Hirst J, Lung T, Oke J, Clarke P, Glasziou P, Neil A, Dunger D, M Colhoun H, Pugh C, Wong G, Perera R, Shine B.

Health Technol Assess. 2014 Feb;18(14):1-128. doi: 10.3310/hta18140. Review.

16.

Association of TERC and OBFC1 haplotypes with mean leukocyte telomere length and risk for coronary heart disease.

Maubaret CG, Salpea KD, Romanoski CE, Folkersen L, Cooper JA, Stephanou C, Li KW, Palmen J, Hamsten A, Neil A, Stephens JW, Lusis AJ, Eriksson P, Talmud PJ, Humphries SE; Simon Broome Research Group; EARSII consortium.

PLoS One. 2013 Dec 12;8(12):e83122. doi: 10.1371/journal.pone.0083122. eCollection 2013.

17.

Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT): urinary screening and baseline biochemical and cardiovascular assessments.

Marcovecchio ML, Woodside J, Jones T, Daneman D, Neil A, Prevost T, Dalton RN, Deanfield J, Dunger DB; AdDIT Investigators.

Diabetes Care. 2014;37(3):805-13. doi: 10.2337/dc13-1634. Epub 2013 Nov 6.

PMID:
24198300
18.

Innovations in capture fisheries are an imperative for nutrition security in the developing world.

Hall SJ, Hilborn R, Andrew NL, Allison EH.

Proc Natl Acad Sci U S A. 2013 May 21;110(21):8393-8. doi: 10.1073/pnas.1208067110. Epub 2013 May 13.

19.

Analysis of the frequency and spectrum of mutations recognised to cause familial hypercholesterolaemia in routine clinical practice in a UK specialist hospital lipid clinic.

Futema M, Whittall RA, Kiley A, Steel LK, Cooper JA, Badmus E, Leigh SE, Karpe F, Neil HA; Simon Broome Register Group, Humphries SE.

Atherosclerosis. 2013 Jul;229(1):161-8. doi: 10.1016/j.atherosclerosis.2013.04.011. Epub 2013 Apr 18.

20.

Stepwise self-titration of oral glucose-lowering medication using a mobile telephone-based telehealth platform in type 2 diabetes: a feasibility trial in primary care.

Nagrebetsky A, Larsen M, Craven A, Turner J, McRobert N, Murray E, Gibson O, Neil A, Tarassenko L, Farmer A.

J Diabetes Sci Technol. 2013 Jan 1;7(1):123-34.

21.

Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study.

Talmud PJ, Shah S, Whittall R, Futema M, Howard P, Cooper JA, Harrison SC, Li K, Drenos F, Karpe F, Neil HA, Descamps OS, Langenberg C, Lench N, Kivimaki M, Whittaker J, Hingorani AD, Kumari M, Humphries SE.

Lancet. 2013 Apr 13;381(9874):1293-301. doi: 10.1016/S0140-6736(12)62127-8. Epub 2013 Feb 22.

22.

Monitoring young people with type 1 diabetes for diabetic nephropathy: potential errors of annual ACR testing.

Oke J, Farmer A, Neil A, Dalton RN, Dunger D, Stevens R.

Diabetes Res Clin Pract. 2013 Mar;99(3):307-14. doi: 10.1016/j.diabres.2012.12.010. Epub 2013 Jan 9.

PMID:
23312483
23.

Use of targeted exome sequencing as a diagnostic tool for Familial Hypercholesterolaemia.

Futema M, Plagnol V, Whittall RA, Neil HA; Simon Broome Register Group, Humphries SE; UK10K.

J Med Genet. 2012 Oct;49(10):644-9. doi: 10.1136/jmedgenet-2012-101189.

24.

Water fluoridation in Victoria, Australia: the value of national research.

Neil A.

Community Dent Oral Epidemiol. 2012 Oct;40 Suppl 2:71-4. doi: 10.1111/j.1600-0528.2012.00723.x.

PMID:
22998308
25.

Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a).

Deshmukh HA, Colhoun HM, Johnson T, McKeigue PM, Betteridge DJ, Durrington PN, Fuller JH, Livingstone S, Charlton-Menys V, Neil A, Poulter N, Sever P, Shields DC, Stanton AV, Chatterjee A, Hyde C, Calle RA, Demicco DA, Trompet S, Postmus I, Ford I, Jukema JW, Caulfield M, Hitman GA; CARDS, ASCOT, and PROSPER Investigators.

J Lipid Res. 2012 May;53(5):1000-11. doi: 10.1194/jlr.P021113. Epub 2012 Feb 24.

26.

Normal levels of inflammatory markers in treated patients with familial hypercholesterolaemia: a cross-sectional study.

Seed M, Betteridge DJ, Cooper J, Caslake M, Durrington PN, Thompson GR, Sattar N, Humphries SE, Neil HA.

JRSM Cardiovasc Dis. 2012 Jun 30;1(3). pii: cvd.2012.012011. doi: 10.1258/cvd.2012.012011. eCollection 2012.

27.

The extent of water fluoridation coverage in Australia.

Neil A.

Aust N Z J Public Health. 2011 Aug;35(4):392-3. doi: 10.1111/j.1753-6405.2011.00747.x. No abstract available.

PMID:
21806737
28.

Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDS trial.

Colhoun HM, Betteridge DJ, Durrington P, Hitman G, Neil A, Livingstone S, Charlton-Menys V, Bao W, Demicco DA, Preston GM, Deshmukh H, Tan K, Fuller JH.

Diabetes. 2011 Sep;60(9):2379-85. doi: 10.2337/db11-0291. Epub 2011 Jul 19.

29.

Association of a sequence variant in DAB2IP with coronary heart disease.

Harrison SC, Cooper JA, Li K, Talmud PJ, Sofat R, Stephens JW, Hamsten A; HIFMECH Consortium, Sanders J, Montgomery H, Neil A; Simon Broome Research Consortium, Humphries SE.

Eur Heart J. 2012 Apr;33(7):881-8. doi: 10.1093/eurheartj/ehr075. Epub 2011 Mar 28.

30.

Telemedicine-supported insulin optimisation in primary care.

Larsen ME, Turner J, Farmer A, Neil A, Tarassenko L.

J Telemed Telecare. 2010;16(8):433-40. doi: 10.1258/jtt.2010.100103. Epub 2010 Sep 14.

PMID:
20841384
31.

The end of the line: who is most at risk from the crisis in global fisheries?

Hall SJ, Dugan P, Allison EH, Andrew NL.

Ambio. 2010 Feb;39(1):78-80. No abstract available.

32.

Telomeres are shorter in myocardial infarction patients compared to healthy subjects: correlation with environmental risk factors.

Maubaret CG, Salpea KD, Jain A, Cooper JA, Hamsten A, Sanders J, Montgomery H, Neil A, Nair D, Humphries SE; HIFMECH consortium, Simon Broome Research Group.

J Mol Med (Berl). 2010 Aug;88(8):785-94. doi: 10.1007/s00109-010-0624-3. Epub 2010 Apr 11.

33.

Maternal but not paternal association of ambulatory blood pressure with albumin excretion in young offspring with type 1 diabetes.

Marcovecchio ML, Tossavainen PH, Acerini CL, Barrett TG, Edge J, Neil A, Shield J, Widmer B, Dalton RN, Dunger DB.

Diabetes Care. 2010 Feb;33(2):366-71. doi: 10.2337/dc09-1152. Epub 2009 Nov 16.

34.

Healthy individuals carrying the PCSK9 p.R46L variant and familial hypercholesterolemia patients carrying PCSK9 p.D374Y exhibit lower plasma concentrations of PCSK9.

Humphries SE, Neely RD, Whittall RA, Troutt JS, Konrad RJ, Scartezini M, Li KW, Cooper JA, Acharya J, Neil A.

Clin Chem. 2009 Dec;55(12):2153-61. doi: 10.1373/clinchem.2009.129759. Epub 2009 Oct 1.

35.

Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS).

Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Charlton-Menys V, DeMicco DA, Fuller JH; CARDS Investigators.

Am J Kidney Dis. 2009 Nov;54(5):810-9. doi: 10.1053/j.ajkd.2009.03.022. Epub 2009 Jun 21.

PMID:
19540640
36.

Implementation of telehealth support for patients with type 2 diabetes using insulin treatment: an exploratory study.

Turner J, Larsen M, Tarassenko L, Neil A, Farmer A.

Inform Prim Care. 2009;17(1):47-53.

37.

Prevalence of abnormal lipid profiles and the relationship with the development of microalbuminuria in adolescents with type 1 diabetes.

Marcovecchio ML, Dalton RN, Prevost AT, Acerini CL, Barrett TG, Cooper JD, Edge J, Neil A, Shield J, Widmer B, Todd JA, Dunger DB.

Diabetes Care. 2009 Apr;32(4):658-63. doi: 10.2337/dc08-1641. Epub 2009 Jan 26.

38.

Statins and familial hypercholesterolaemia.

Neil A, Humphries SE.

BMJ. 2009 Jan 21;338:a3041. doi: 10.1136/bmj.a3041. No abstract available.

PMID:
19158168
39.

Targets of statin therapy: LDL cholesterol, non-HDL cholesterol, and apolipoprotein B in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS).

Charlton-Menys V, Betteridge DJ, Colhoun H, Fuller J, France M, Hitman GA, Livingstone SJ, Neil HA, Newman CB, Szarek M, DeMicco DA, Durrington PN.

Clin Chem. 2009 Mar;55(3):473-80. doi: 10.1373/clinchem.2008.111401. Epub 2009 Jan 15.

40.

Potential impact of omega-3 treatment on cardiovascular disease in type 2 diabetes.

Hartweg J, Farmer AJ, Holman RR, Neil A.

Curr Opin Lipidol. 2009 Feb;20(1):30-8.

PMID:
19133409
41.

Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study.

Neil A, Cooper J, Betteridge J, Capps N, McDowell I, Durrington P, Seed M, Humphries SE.

Eur Heart J. 2008 Nov;29(21):2625-33. doi: 10.1093/eurheartj/ehn422. Epub 2008 Oct 7.

42.

Long-term follow-up after tight control of blood pressure in type 2 diabetes.

Holman RR, Paul SK, Bethel MA, Neil HA, Matthews DR.

N Engl J Med. 2008 Oct 9;359(15):1565-76. doi: 10.1056/NEJMoa0806359. Epub 2008 Sep 10.

43.

10-year follow-up of intensive glucose control in type 2 diabetes.

Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA.

N Engl J Med. 2008 Oct 9;359(15):1577-89. doi: 10.1056/NEJMoa0806470. Epub 2008 Sep 10.

44.

The safety and tolerability of atorvastatin 10 mg in the Collaborative Atorvastatin Diabetes Study (CARDS).

Newman CB, Szarek M, Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Demicco DA, Auster S, Fuller JH; Cards Investigators.

Diab Vasc Dis Res. 2008 Sep;5(3):177-83. doi: 10.3132/dvdr.2008.029.

PMID:
18777490
45.

Development of sensitive and specific age- and gender-specific low-density lipoprotein cholesterol cutoffs for diagnosis of first-degree relatives with familial hypercholesterolaemia in cascade testing.

Starr B, Hadfield SG, Hutten BA, Lansberg PJ, Leren TP, Damgaard D, Neil HA, Humphries SE.

Clin Chem Lab Med. 2008;46(6):791-803. doi: 10.1515/CCLM.2008.135.

PMID:
18601600
46.

You are what your mother eats: evidence for maternal preconception diet influencing foetal sex in humans.

Mathews F, Johnson PJ, Neil A.

Proc Biol Sci. 2008 Jul 22;275(1643):1661-8. doi: 10.1098/rspb.2008.0105.

47.

Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial.

Simon J, Gray A, Clarke P, Wade A, Neil A, Farmer A; Diabetes Glycaemic Education and Monitoring Trial Group.

BMJ. 2008 May 24;336(7654):1177-80. doi: 10.1136/bmj.39526.674873.BE. Epub 2008 Apr 17.

48.

Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study.

Amin R, Widmer B, Prevost AT, Schwarze P, Cooper J, Edge J, Marcovecchio L, Neil A, Dalton RN, Dunger DB.

BMJ. 2008 Mar 29;336(7646):697-701. doi: 10.1136/bmj.39478.378241.BE. Epub 2008 Mar 18.

49.

Stability of soluble adhesion molecules, selectins, and C-reactive protein at various temperatures: implications for epidemiological and large-scale clinical studies.

Hartweg J, Gunter M, Perera R, Farmer A, Cull C, Schalkwijk C, Kok A, Twaalfhoven H, Holman R, Neil A.

Clin Chem. 2007 Oct;53(10):1858-60. Epub 2007 Aug 3.

50.

Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial.

Farmer A, Wade A, Goyder E, Yudkin P, French D, Craven A, Holman R, Kinmonth AL, Neil A.

BMJ. 2007 Jul 21;335(7611):132. Epub 2007 Jun 25.

Supplemental Content

Loading ...
Support Center